Our findings are in agreement with Dooley and ten Dijke (2012) who stated that TGF-β is recognized as a major profibrogenic cytokine included in hepatic fibrosis and its signaling is involved in all disease progression stages, from hepatic injury which include inflammation and fibrosis, to cirrhosis and cancer. The gene discussed is TGFB1; the disease is Cirrhosis.